Stereotactic body radiotherapy shows favourable long-term outcomes and low severe toxicity in studies

Stereotactic body radiotherapy has shown good long-term outcomes and low rates of severe toxicity, making it a valid treatment option for men with low- and intermediate-risk prostate cancer, according to three studies recently presented at the 36th European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting
Prostate Cancer News Today

One Response to “Stereotactic body radiotherapy shows favourable long-term outcomes and low severe toxicity in studies”

  1. Tony Murphy

    Thanks. Good to hear of this progress with SABR.
    Is there anything at ESTRO about proton treatment for prostate cancer?
    There was an extensive article in the I newspaper on Saturday about Prague treating some men willing to pay for their own treatment over there.